Oct 2026
Genotype and arrhythmic risk in dilated cardiomyopathy.
K. Padalia, A. Fornaro, B. Claggett et al.
· European Heart Journal · 0 citations
We have 4 of 12 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Sep 2026
Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry.
BACKGROUND Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown. METHODS In this observational cohort study, we analyzed...
I. Balakrishnan, A. Heymans, B. Claggett et al.
· Circulation: Heart Failure · 0 citations
Sep 2026
The molecular landscape of hypertrophic cardiomyopathy across disease stages and genotypes.
Unsupervised and supervised machine learning approaches distinguished HCM from dilated cardiomyopathy and accurately predicted genotype status in early-stage HCM from cell type-resolved transcriptional profiles, revealing widespread genotype-driven remodeling.
E. Adami, Yuri Kim, Sean L. Zheng et al.
· Science Translational Medici... · 1 citation
Open access
Jul 2026
Damaging RBM20 E-rich domain variants are not rescued by gene replacement
The data indicate that pathogenic E-rich domain variants reduce RBM20 protein abundance, but that their mechanism is unlikely to be explained by haploinsufficiency alone.
Bai Fang, Kaiser Chua, Daniel Y. Li et al.
· bioRxiv · 0 citations